FDA Inspection
Nathan M. Bass, MD, PhDNathan M. Bass, MD, PhD – FDA Inspection, May 9, 2014
Record Details
This FDA Inspection record concerns Nathan M. Bass, MD, PhD, with an inspection on May 9, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Nathan M. Bass, MD, PhD
- Inspection Date
- May 9, 2014
- Product Type
- Biologics
View Company Profile
ID · af6db319-b2cf-44f1-b1cc-3c05cd7dbd89
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 876832
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 812.110(b)Investigator non-compliance with agreement/plan/regulations
- 21 CFR 50.27(a)Consent form not approved/signed/dated
- 21 CFR 812.140(a)(3)(i)Investigator records of informed consent inadequate
- 21 CFR 812.140(a)(3)Investigator"s subject records inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nathan M. Bass, MD, PhD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Nathan M. Bass, MD, PhD
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.